NEJM This Week — September 23, 2021
Featuring articles on artemisinin-resistant malaria in Africa, safety and efficacy of the NVX-CoV2373 vaccine, subcutaneous antibody combination and Covid-19, tebentafusp for uveal melanoma, reenergizing HCV vaccine development, and HER2-mutated breast cancer and overcoming drug resistance; a review article on mesothelioma; a case report of a boy with fever and developmental regression; and Perspective articles on public health law after Covid-19 and on revitalizing the U.S. primary care infrastructure.
